Long-term follow-up study of people with psoriasis
Collects health information and samples from people with psoriasis to support future research.
Plain-language title generated from the registry record
Registry title: ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
Key facts
- Where
- Leuven, BelgiumSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 70 years old?
Source: NCT05122039, who can take part
Where in Belgium
- UZ LeuvenLeuven, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Trial code
- NCT05122039
- Record updated
- 1 July 2024
- Original description
The main purpose of the PICASSO-project is to facilitate future psoriasis-research in dermatology. This register biobank will enable us to perform research in the field of metabolomics, mRNA-expression, cardiovascular impact and the microbiome. The final aims are patient stratification, better insight in disease-evolution and improved understanding of markers that predispose to severe disease.Read full original descriptionShow less
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
The main purpose of the PICASSO-project is to facilitate future psoriasis-research in dermatology. This register biobank will enable us to perform research in the field of metabolomics, mRNA-expression, cardiovascular impact and the microbiome. The final aims are patient stratification, better insight in disease-evolution and improved understanding of markers that predispose to severe disease.
Inclusion: Clinical signs of Psoriasis since >3 years; adults (70 years old or less) and children (>12 years old); willing and able to understand and sign the informed consent (plus legal representative in case of a minor).
Exclusion: disease duration longer than 3 years; unwilling or unable to understand and sign the informed consent.